EVH.US Evolent Health Inc

Healthcare Health Care Technology USA Stocks
4.90 USD
Close of Nov 14, 2026
2.10 6.26
Market cap
USD 554M
P/E
-
P/B
1.45x
ROE
-28.1%
Dividend yield
2.01%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is EVH.US undervalued?

Graham number

The Graham number of Evolent Health Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Evolent Health Inc fundamental analysis

No fundamental analysis for Evolent Health Inc yet.

Evolent Health Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Evolent Health Inc

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technolo…

Full company profile